XML 21 R9.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
Mar. 31, 2024
Sep. 30, 2023
Mar. 31, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Operating activities:              
Net income $ 41,767 $ 28,214 $ 36,014 $ 26,074 $ 108,953 $ 100,737  
Adjustments to reconcile net income to net cash provided by operating activities:               
Depreciation         16,961 15,658  
Amortization         1,538 1,575  
Deferred income taxes         (5,570) (734)  
Provision for credit losses 83   1,734   (51) 4,385  
Stock-based compensation costs         1,034 517  
Unrealized gain on investments (200)   0   (531) 0  
Gain on sale of assets         (5,513) (6,297)  
Equity in earnings of unconsolidated affiliates, net of distributions         (4,788) (4,718)  
Changes in current assets and liabilities, net of acquisitions:              
Receivables         (97,980) (5,828)  
Due from related-party         (763) 1,381  
Costs and estimated earnings in excess of billings         (15,573) (44,802) $ (4,622)
Inventories         (4,214) (8,984)  
Other current assets         (2,303) (2,512)  
Accounts payable         44,265 (11,125)  
Due to related-party         10 356  
Billings in excess of costs and estimated earnings         23,431 12,566 32,042
Other current liabilities         32,760 6,540  
Other noncurrent changes         (8,984) 2,647  
Net cash provided by operating activities         82,682 61,362  
Investing activities:              
Capital expenditures         (34,506) (28,134)  
Net proceeds from sale or disposition of property         9,587 12,247  
Investments         (570) (535)  
Net cash used in investing activities         (25,489) (16,422)  
Financing activities:              
Repayment of related-party notes payable         0 (45,000)  
Repayment of related-party short-term notes payable         0 (27,000)  
Net amounts received from related-party cash management program         45,994 62,527  
Transfers to Centennial         (104,201) (37,026)  
Net cash used in financing activities         (58,207) (46,499)  
Decrease in cash and cash equivalents         (1,014) (1,559)  
Cash and cash equivalents - beginning of period   $ 1,567   $ 2,112 1,567 2,112 2,112
Cash and cash equivalents - end of period $ 553   $ 553   $ 553 $ 553 $ 1,567